Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …
If your investing decisions were based solely on past performance, Pfizer Inc. (NYSE: PFE) would be the better stock to buy than GlaxoSmithKline plc (NYSE: GSK). Over the past 12 months, three years, five years, and 10 years, Pfizer's …
Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views. (ShareCast News) - GlaxoSmithKline's full year results will be under the microscope on Wednesday with the shares down by a quarter …
LONDON (AP) — Drugmaker GlaxoSmithKline saw it shares rise Wednesday after it said it was sticking to a generous dividend and that its blockbuster asthma medicine, Advair, was weathering competition from generic versions. Shares …
Over the past 10 years GlaxoSmithKline plc (LSE:GSK) has returned an average of 5.00% per year from dividend payouts. The company currently pays out a dividend yield of 5.97% to shareholders, making it a relatively attractive …